HOME >> BIOLOGY >> NEWS
Autism media fellowship available at Vanderbilt University

NASHVILLE, Tenn. - Journalists are encouraged to apply to attend a media fellowship, "Autism: Rates, Causes and Treatment," hosted by Vanderbilt University in conjunction with the Council for the Advancement and Support of Education April 10-13 in Nashville, Tenn. At this fellowship, journalists will have an opportunity to meet with leading autism researchers and affected families to learn about the latest advances in understanding this complex disorder.

Autism has been a top media story across the nation this month, with stories by The Wall Street Journal, the New York Times, Newsweek and "The Today Show" featuring the work of the Vanderbilt Kennedy Center for Research on Human Development to understand and treat this disorder. New guidelines released by the Centers for Disease Control Feb. 21 to help parents identify the potential early warning signs of autism are sure to keep this story in the forefront of public attention.

The fellowship application deadline has been extended to March 4. Contact Melanie Catania at 615-322-7970 or melanie.catania@vanderbilt.edu or visit http://www.vanderbilt.edu/news/autism for more information.


'"/>

Contact: Melanie Catania
melanie.catania@vanderbilt.edu
615-322-7970
Vanderbilt University
24-Feb-2005


Page: 1

Related biology news :

1. Autism theory put to the test with new technology
2. Autism-related proteins control nerve excitability, researchers find
3. 1 month post launch, Interactive Autism Network reports 13,000 participants
4. Autism linked to mirror neuron dysfunction
5. ASMs new media campaigns take the gold
6. Endosome-mediated signaling in plants
7. Nanotechnology requires immediate changes in EPA
8. Oxidative stress stimulates p38 MAPK-mediated tumor suppression
9. Cells, dyes and videotape: Online scientific methods journal incorporates multimedia
10. NASA hosts Arctic sea ice media teleconference
11. NASA announces media briefing about ocean plant growth

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/1/2020)... SOMERSET, N.J. (PRWEB) , ... July 01, 2020 ... ... today announced that it had completed the purchase of Teva-Takeda Pharmaceuticals’ packaging facility ... with the company’s existing Japanese clinical supply facility located in Kakegawa, the new ...
(Date:6/28/2020)... ... June 25, 2020 , ... ... R&D, today announced that it has entered into a multi-year contract with ... to support their translational and clinical research strategy to discover and develop ...
(Date:6/25/2020)... ... June 24, 2020 , ... eClinical Solutions LLC , ... that accelerate drug development, is collaborating with Karyopharm Therapeutics (Nasdaq: KPTI ) ... with severe COVID-19. This is the first study of an XPO1 inhibitor in ...
Breaking Biology News(10 mins):
(Date:7/31/2020)... ... ... R3 Stem Cell International is now offering patients the opportunity to receive four ... may choose which extremities they would like treated. , Several studies have shown just ... R3 International, umbilical cord tissue is obtained from a lab with a long history ...
(Date:7/31/2020)... ... July 29, 2020 , ... eSource has long been touted as the solution ... history of eSource, the reasons it did not take off as quickly as people ... the industry is moving towards capturing data electronically for clinical trials and then repurposing ...
(Date:7/18/2020)... ... July 16, 2020 , ... “We are thrilled to deliver this new technology ... technology of its kind on the market and we were pleased that the IFT ... of traditional cultured ingredients, creating a natural way to extend the shelf life and ...
(Date:7/10/2020)... ... July 09, 2020 , ... ... (PTU) is commonly used to suppress pigment formation in zebrafish embryos, maintaining optical ... team led by Dr MA has been using the zebrafish model to investigate ...
Breaking Biology Technology:
Cached News: